1.90 (-%)
As of Jun 04, 2024
Source:
We are a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. We have concentrated our research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Built on more than a decade of foundational science on extracellular tRNA synthetase biology and its effect on immune responses, we have built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets, such as neuropilin-2 (NRP2).
Country | United States |
Headquarters | san diego, california |
Phone Number | 8587318389 |
Industry | manufacturing |
CEO | Sanjay S. Shukla |
Website | atyrpharma.com |